Nirmatrelvir Plus Ritonavir for Ambulatory COVID-19: Expanding Evidence, Expanding Role. Anesi GL, Maguire C. Ann Intern Med 2022 Dec 13. doi: 10.7326/M22-3427.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Anesi GL, Maguire C. Nirmatrelvir Plus Ritonavir for Ambulatory COVID-19: Expanding Evidence, Expanding Role. Ann Intern Med 2022 Dec 13. doi: 10.7326/M22-3427.
PMID: 36508735